- Home
- USEA vs CRIS Comparison
USEA vs CRIS Comparison
Compare USEA & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- CRIS
- Stock Information
- Founded
- USEA 2004
- CRIS 2000
- Country
- USEA Greece
- CRIS United States
- Employees
- USEA N/A
- CRIS N/A
- Industry
- USEA Marine Transportation
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USEA Consumer Discretionary
- CRIS Health Care
- Exchange
- USEA Nasdaq
- CRIS Nasdaq
- Market Cap
- USEA 15.6M
- CRIS 14.6M
- IPO Year
- USEA N/A
- CRIS 2000
- Fundamental
- Price
- USEA $1.63
- CRIS $1.25
- Analyst Decision
- USEA
- CRIS Strong Buy
- Analyst Count
- USEA 0
- CRIS 2
- Target Price
- USEA N/A
- CRIS $16.50
- AVG Volume (30 Days)
- USEA 56.0K
- CRIS 96.5K
- Earning Date
- USEA 11-11-2025
- CRIS 11-06-2025
- Dividend Yield
- USEA 7.74%
- CRIS N/A
- EPS Growth
- USEA N/A
- CRIS N/A
- EPS
- USEA N/A
- CRIS N/A
- Revenue
- USEA $42,025,000.00
- CRIS $11,650,000.00
- Revenue This Year
- USEA N/A
- CRIS $2.72
- Revenue Next Year
- USEA N/A
- CRIS $8.27
- P/E Ratio
- USEA N/A
- CRIS N/A
- Revenue Growth
- USEA N/A
- CRIS 13.56
- 52 Week Low
- USEA $1.00
- CRIS $1.02
- 52 Week High
- USEA $2.10
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- USEA 61.90
- CRIS 47.93
- Support Level
- USEA $1.55
- CRIS $1.08
- Resistance Level
- USEA $1.74
- CRIS $1.21
- Average True Range (ATR)
- USEA 0.10
- CRIS 0.13
- MACD
- USEA 0.01
- CRIS 0.00
- Stochastic Oscillator
- USEA 90.74
- CRIS 74.16
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of seven dry bulk vessels, comprising three Panamax, two Capesize and two Kamsarmax vessels with an aggregate cargo-carrying capacity of approximately 750,758 dwt.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.